Paul J Chiao Selected Research

Paul J Chiao Research Topics

Disease

55	Neoplasms (Cancer) 01/2023 - 09/2002
38	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2003
15	Adenocarcinoma 12/2022 - 11/2002
15	Carcinogenesis 03/2016 - 09/2002
10	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2003
4	Inflammation (Inflammations) 02/2006 - 11/2003
2	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2005
2	Pathologic Processes 06/2021 - 09/2004
2	Hypoxia (Hypoxemia) 09/2020 - 06/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2018 - 02/2007
2	Colonic Neoplasms (Colon Cancer) 09/2006 - 07/2005
2	Multiple Myeloma 04/2006 - 07/2005
1	Plasmacytoma 01/2023
1	Bites and Stings (Sting) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2020
1	Adenocarcinoma of Lung 01/2020

Drug/Important Bio-Agent (IBA)

22	NF-kappa B (NF-kB)IBA 11/2012 - 09/2002
13	Gemcitabine FDA Link 10/2022 - 07/2005
9	Phosphotransferases (Kinase)IBA 04/2024 - 01/2005
9	Transcription Factors (Transcription Factor)IBA 06/2022 - 09/2002
5	Proteins (Proteins, Gene)FDA Link 11/2020 - 07/2004
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 01/2003
5	Antineoplastic Agents (Antineoplastics)IBA 02/2007 - 01/2003
5	Bortezomib (Velcade)FDA Link 04/2006 - 09/2002
4	CytokinesIBA 01/2022 - 01/2003
4	LuciferasesIBA 08/2011 - 05/2007
4	Small Interfering RNA (siRNA)IBA 08/2011 - 04/2006
3	Long Noncoding RNAIBA 01/2023 - 01/2017
3	AgarIBA 06/2022 - 10/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2007
3	Mitogen-Activated Protein KinasesIBA 11/2017 - 01/2005
3	Oncogene Proteins (Oncogene Protein)IBA 01/2016 - 09/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2012 - 02/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2012 - 09/2002
3	Interleukin-8 (Interleukin 8)IBA 01/2006 - 01/2003
2	Messenger RNA (mRNA)IBA 01/2022 - 07/2004
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 11/2020
2	Drug CombinationsIBA 01/2022 - 10/2009
2	Biomarkers (Surrogate Marker)IBA 06/2021 - 09/2011
2	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 09/2006
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 10/2009
2	Indicators and Reagents (Reagents)IBA 09/2020 - 07/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 02/2006
2	phenethyl isothiocyanate (PEITC)IBA 03/2015 - 09/2006
2	Epidermal Growth Factor (EGF)IBA 12/2012 - 01/2003
2	Doxycycline (Periostat)FDA LinkGeneric 11/2012 - 10/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012 - 09/2006
2	NF-KappaB Inhibitor alphaIBA 08/2010 - 09/2002
2	DNA (Deoxyribonucleic Acid)IBA 10/2009 - 01/2003
2	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 08/2009 - 05/2007
2	nafamostatIBA 08/2009 - 05/2007
2	Interleukin-1alpha (Interleukin 1 alpha)IBA 05/2009 - 04/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 04/2008 - 11/2002
2	GenisteinIBA 02/2007 - 10/2005
2	Proteasome InhibitorsIBA 04/2006 - 07/2005
2	ErbB Receptors (EGF Receptor)IBA 07/2005 - 01/2003
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2005 - 09/2004
1	nardilysinIBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	KynurenineIBA 01/2023
1	Annexin A5IBA 12/2022
1	Keratin-19 (Keratin 19)IBA 12/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2022
1	ThrombomodulinIBA 10/2022
1	Liver X ReceptorsIBA 06/2022
1	LigandsIBA 06/2022
1	OligonucleotidesIBA 06/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 06/2022
1	GW 3965IBA 06/2022
1	Serine (L-Serine)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	Epoxide HydrolasesIBA 01/2022
1	HydrolasesIBA 01/2022
1	ProdrugsIBA 01/2022
1	Carboxylesterase (Hydrolase S)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	toripalimabIBA 01/2022
1	Circular RNAIBA 06/2021
1	RNA (Ribonucleic Acid)IBA 06/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 11/2020
1	folfirinoxIBA 11/2020
1	Carbonic Anhydrase IXIBA 09/2020
1	BradykininIBA 09/2020
1	Oxygen (Dioxygen)IBA 09/2020
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	AntiportersIBA 01/2020
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020
1	Glutathione (Reduced Glutathione)IBA 01/2020
1	Cystine (L-Cystine)IBA 01/2020
1	NADP (NADPH)IBA 06/2019
1	PotassiumIBA 09/2018
1	tartaric acid (tartrate)FDA Link 09/2018

Therapy/Procedure

10	Therapeutics 12/2022 - 07/2005
7	Drug Therapy (Chemotherapy) 12/2022 - 01/2003
2	Immunotherapy 01/2022 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 11/2020 - 08/2009
2	Oral Administration 08/2011 - 07/2005
2	Radiotherapy 08/2004 - 01/2003
1	Neoadjuvant Therapy 12/2022